A door opens to ensure the gold standard of FeNO testing is available in Latin America. Image Credit: Bedfont Scientific Ltd. Bedfont® Scientific Limited, world leaders in breath analysis, with over 47 years of experience in the manufacturing and distribution of breath analysis devices have partnered with worldwide respected medical company Geratherm® Group, to enable them to manufacture a Fractional exhaled Nitric Oxide (FeNO) testing device.
Related Stories Bedfont’s NObreath® monitor for airway inflammation has been cleared for sale in the USA World Asthma Day 2024 Webinar: How embracing FeNO Testing can Transform Asthma Care Prioritising Lung Health: How FeNO can help to tackle Lung Conditions, the UK's 3rd Largest Threat Geratherm® Group predominantly known for their medical glass thermometers are an internationally aligned group that develop and produce medical solutions from respiratory therapy to women’s health at its five locations in Germany. They export 82% of their products to over 60 different countries every year, with many products in use in practices, clinics and rehabilitation facilities worldwide. Their Latin America sales office, which was founded in May 2002 based in Brazil, is currently the focal point for sales, warehousing and customer service from Mexico to Chile for the entire group.
This is where the partnership begins between Bedfont® and Geratherm®. Marcio Souza, CEO of Geratherm® Medical Latin America visited the Bedfont® premises back.